UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Atara Biotherapeutics
ATRA
$75.5M
| $32.7M | 0.03% |
24,780
+18,615
| +302% | +$21.4M |
|
|
CPN
527
DELISTED
Calpine Corporation
CPN
| $32.6M | 0.03% |
1,814,038
+46,991
| +3% | +$980K |
|
528
Cenovus Energy
CVE
$55.7B
| $32.5M | 0.03% |
2,034,556
-10,644
| -0.5% | -$185K |
|
529
AGNC Investment
AGNC
$12.4B
| $32.4M | 0.03% |
1,765,672
+566,874
| +47% | +$11.7M |
|
|
SJR
530
DELISTED
Shaw Communications Inc.
SJR
| $32.3M | 0.03% |
1,481,327
+73,628
| +5% | +$1.65M |
|
531
Dick's Sporting Goods
DKS
$17.5B
| $32.1M | 0.03% |
620,449
+363,060
| +141% | +$20M |
|
|
MDR
532
DELISTED
McDermott International
MDR
| $31.6M | 0.03% |
1,970,995
-191,969
| -9% | -$3M |
|
533
Cintas
CTAS
$81.9B
| $31.5M | 0.03% |
1,487,844
-79,700
| -5% | -$1.67M |
|
534
Hilton Worldwide
HLT
$72.1B
| $31.5M | 0.03% |
380,534
+91,930
| +32% | +$8.07M |
|
|
TW
535
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $31.4M | 0.03% |
249,922
-11,598
| -4% | -$1.56M |
|
536
TechnipFMC
FTI
$28.1B
| $31.4M | 0.03% |
1,017,600
+18,910
| +2% | +$582K |
|
537
MacroGenics
MGNX
$235M
| $31.4M | 0.03% |
826,141
+6,032
| +0.7% | +$198K |
|
538
KLA
KLAC
$239B
| $31.2M | 0.03% |
5,549,270
+12,450
| +0.2% | +$72.8K |
|
539
Advance Auto Parts
AAP
$3.35B
| $31.2M | 0.03% |
195,576
+5,485
| +3% | +$838K |
|
540
Unum
UNM
$13.6B
| $31M | 0.03% |
868,420
-3,353
| -0.4% | -$117K |
|
541
Travel + Leisure Co
TNL
$4.66B
| $30.9M | 0.03% |
834,446
-4,561
| -0.5% | -$179K |
|
542
CDW
CDW
$18.9B
| $30.8M | 0.03% |
899,816
+835,257
| +1,294% | +$31.2M |
|
543
Murphy Oil
MUR
$5.7B
| $30.8M | 0.03% |
741,981
+30,006
| +4% | +$1.37M |
|
|
LLL
544
DELISTED
L3 Technologies, Inc.
LLL
| $30.8M | 0.03% |
271,208
-12,704
| -4% | -$1.51M |
|
|
KSU
545
DELISTED
Kansas City Southern
KSU
| $30.7M | 0.03% |
336,891
+3,631
| +1% | +$358K |
|
546
CenterPoint Energy
CNP
$27.7B
| $30.5M | 0.03% |
1,601,690
+31,553
| +2% | +$638K |
|
547
Arista Networks
ANET
$227B
| $30.4M | 0.03% |
+5,953,632
| New | +$26.6M |
|
548
Silicon Laboratories
SLAB
$7.17B
| $30.4M | 0.03% |
563,023
-32,798
| -6% | -$1.75M |
|
549
ON Semiconductor
ON
$31.8B
| $30.3M | 0.03% |
2,595,789
+2,208,070
| +570% | +$27.1M |
|
550
American Water Works
AWK
$26.7B
| $30.3M | 0.03% |
623,565
-14,629
| -2% | -$770K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.